Chinook Therapeutics Inc.

(NASDAQ:KDNY) Trade

By |

Equities News

Company chart and information is provided by TradingView based on 15-minute-delayed data.


Profile

Chinook Therapeutics Inc is a clinical-stage biotechnology company. It is engaged in developing precision medicines for kidney diseases. The products of the company are focused on rare, severe chronic kidney disorders.

Contact Information

Website: www.chinooktx.com
Email: investors@chinooktx.com
Main Phone: +1 604 343-1552
Address: 1600 Fairview Avenue E
State: WA
City / Town: Seattle
Country: US
Postal Code: 98102

Issuer Information

Exchange: NGS
CEO: Eric L. Dobmeier
Employees: 96
NAICS: Research and Development in Biotechnology (except Nanobiotechnology)(541714)

Equities News

(%)
Company data no longer available
Last Price N/A Change $ N/A Change % N/A Tick N/A
Bid N/A Bid Size N/A Ask N/A Ask Size N/A
Open N/A High N/A Low N/A Prev Close N/A
Last Trade Volume N/A 52 Wk Hi N/A 52 Wk Low N/A
Market Cap N/A Ex-Div Date N/A Div Rate N/A Yield N/A
Shares N/A EPS (TTM) N/A PE Ratio N/A Exchange N/A